New study explores smarter antibiotic dosing for obese patients
NCT ID NCT06690905
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 24 times
Summary
This study looked at whether giving the antibiotic piperacillin-tazobactam as a longer infusion helps people with obesity reach the right drug level in their blood. It included 45 hospitalized adults with obesity who needed this antibiotic. The main goal was to see if a larger study is possible, not to prove the treatment works better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Charles- Le Moyne
Greenfield Park, Quebec, J4V 2H1, Canada
Conditions
Explore the condition pages connected to this study.